193 related articles for article (PubMed ID: 20458678)
1. [Antipsychotics and metabolic abnormalities in children and adolescents: a review of the literature and some recommendations].
Overbeek WA; de Vroede MA; Lahuis BE; Hillegers MH; de Graeff-Meeder ER
Tijdschr Psychiatr; 2010; 52(5):311-20. PubMed ID: 20458678
[TBL] [Abstract][Full Text] [Related]
2. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
3. [Reaction on 'Antipsychotics and metabolic abnormalities in children and adolescents; a review of the literature and some recommendations'].
Cohen D; de Hert M
Tijdschr Psychiatr; 2010; 52(8):605-7; author reply 608. PubMed ID: 20698002
[No Abstract] [Full Text] [Related]
4. [The metabolic syndrome and antipsychotics in children and adolescents].
Dori N; Green T
Harefuah; 2011 Oct; 150(10):791-6, 814, 813. PubMed ID: 22111125
[TBL] [Abstract][Full Text] [Related]
5. [Schizophrenia and antipsychotics associated with the metabolic syndrome. An overview].
Scheepers-Hoeks AM; Wessels-Basten SJ; Scherders MJ; Bravenboer B; Loonen AJ; Kleppe RT; Grouls RJ
Tijdschr Psychiatr; 2008; 50(10):645-54. PubMed ID: 18951343
[TBL] [Abstract][Full Text] [Related]
6. Bridging the gap from evidence to policy and practice: reducing the progression to metabolic syndrome for children and adolescents on antipsychotic medication.
Eapen V; Shiers D; Curtis J
Aust N Z J Psychiatry; 2013 May; 47(5):435-42. PubMed ID: 23047958
[TBL] [Abstract][Full Text] [Related]
7. Nursing care of clients treated with atypical antipsychotics who have a risk of developing metabolic instability and/or type 2 diabetes.
Edward KL; Rasmussen B; Munro I
Arch Psychiatr Nurs; 2010 Feb; 24(1):46-53. PubMed ID: 20117688
[TBL] [Abstract][Full Text] [Related]
8. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
Yogaratnam J; Biswas N; Vadivel R; Jacob R
East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
[TBL] [Abstract][Full Text] [Related]
9. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome in patients with psychotic disorders: diagnostic issues, comorbidity and side effects of antipsychotics.
Kozumplik O; Uzun S; Jakovljević M
Psychiatr Danub; 2010 Mar; 22(1):69-74. PubMed ID: 20305594
[TBL] [Abstract][Full Text] [Related]
11. Use of antipsychotics in children and adolescents.
Findling RL; Steiner H; Weller EB
J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
[TBL] [Abstract][Full Text] [Related]
12. [Challenges of the use of antipsychotics in children and adolescents].
Portnova AA; Sivolap YP
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(11):123-127. PubMed ID: 31851183
[TBL] [Abstract][Full Text] [Related]
13. [Antipsychotic prescription assessment in general practice: metabolic effects].
Gignoux-Froment F; de Montleau F; Saravane D; Verret C
Encephale; 2012 Dec; 38(6):453-9. PubMed ID: 23200610
[TBL] [Abstract][Full Text] [Related]
14. Putting metabolic side effects into perspective: risks versus benefits of atypical antipsychotics.
Meltzer HY
J Clin Psychiatry; 2001; 62 Suppl 27():35-9; discussion 40-1. PubMed ID: 11806488
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Metabolic Effects in French-Canadian Children and Adolescents Treated with Second-Generation Antipsychotics in Monotherapy or Polytherapy: A 24-Month Descriptive Retrospective Study.
Ilies D; Huet AS; Lacourse E; Roy G; Stip E; Amor LB
Can J Psychiatry; 2017 Dec; 62(12):827-836. PubMed ID: 28673098
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of antipsychotics in prepubertal children: a retrospective chart review.
Ebert T; Midbari Y; Shmilovitz R; Kosov I; Kotler M; Weizman A; Ram A
J Child Adolesc Psychopharmacol; 2014 May; 24(4):218-22. PubMed ID: 24816004
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents.
McIntyre RS; Jerrell JM
Arch Pediatr Adolesc Med; 2008 Oct; 162(10):929-35. PubMed ID: 18838645
[TBL] [Abstract][Full Text] [Related]
18. Schizophrenia, antipsychotics and metabolic disease.
Reynolds GP
J Psychopharmacol; 2007 Jun; 21(4):355-6. PubMed ID: 17656424
[No Abstract] [Full Text] [Related]
19. Review on the current use of antipsychotic drugs in children and adolescents.
Almandil NB; Wong IC
Arch Dis Child Educ Pract Ed; 2011 Oct; 96(5):192-6. PubMed ID: 21771730
[TBL] [Abstract][Full Text] [Related]
20. [The appearance of metabolic syndrome in treatment with atypical antipsychotics].
Mosolov SN; Kabanov SO
Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):62-9. PubMed ID: 14681970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
